Blood cancer clinical trials starting at Wellington Hospital

Blood cancer clinical trials starting at Wellington Hospital
The manufacturing process for the therapy has been automated. (Image: Malaghan Institute)
Staff reporters
The Malaghan Institute is starting a phase 2 clinical trial of its CAR T-cell cancer therapy this month at Wellington Hospital.The Wellington-based medical research charity said the trial was going ahead on the back of promising phase 1 results. The earlier trial had indicated the therapy was safer than existing commercial CAR T-cell therapies and remained highly effective for B-cell non-Hodgkin lymphomas.Malaghan Institute clinical director Robert Weinkove said the phase 2 trial was a major step towards individualised CAR T-cell therapy becomi...